Skip to content

DM1, Effects of Carbo-Counting on Glycemic Control

Effectiveness of Carbohydrate Counting on Glycaemic Control in T1DM Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03554590
Enrollment
50
Registered
2018-06-13
Start date
2016-12-31
Completion date
2020-01-31
Last updated
2018-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes Mellitus

Keywords

carbohydrate counting, insulin therapy

Brief summary

Carbohydrate counting is the most effective meal-planning strategy in type 1 diabetes (T1DM) to optimize insulin therapy. However, it may lead to weight gain and unhealthy eating habits. This study aims to compare glycemic control parameters, anthropometric measurements and dietary lifestyle in T1DM patients who practice CHO-counting, after attending a structured course to learn how to manage this tecnique, vs a control Group, in a follow up period of 2 years.

Detailed description

patients with type 1 DM will be enrolled in the study. patients in the intervention group will attend a 5-lessons training to learn how to manage insulin therapy depending on the amount of carbohydrates in their meals, patients in the control group will be follow according to the the standard care. after the follow up period glycometabolic, anthropometric parameters and dietary lifestyle changes will be compared between the two groups.

Interventions

patients will attend a 5 meetings-structured training to learn how to manage their insulin therapy depending on the amount of carbohydrates contained in foods

BEHAVIORALinsulin therapy according to standard care

patients will not manage their insulin therapy depending on the amount of carbohydrates contained in foods, but will follow a fix basal bolus scheme

Sponsors

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* type 1 diabetes mellitus * insulin therapy * HbA1c from 5.5 to 10%

Exclusion criteria

* pregnancy * celiac disease * hepatic impairment * chronic renal failure

Design outcomes

Primary

MeasureTime frameDescription
glycemic control2 yearsHbA1c

Secondary

MeasureTime frameDescription
anthropometric parameters: WAIST AND HIP CIRCUMFERENCE2 yearsvariations in waist and hip circumference (units: cm)
anthropometric parameters: BIOIMPEDENTIOMETRIC PARAMETERS2 yearsfat mass and free fat mass (units: % of total mass)
anthropometric parameters: BMI2 yearsvariations in body mass index (BMI: units kg/m2), weight and height will be combined to report BMI in kg/m\^2
glucose variability: mean and standard deviation of self monitoring blood glucose (SMBG)2 YEARSmean and standard deviation of self monitoring blood glucose (SMBG), data collected from glucometers, units: mg/dl
glucose variability: incidence of hypoglycaemia2 YEARSincidence of hypoglycaemia (SMBG \< 70 mg/dl), units: n° episodes/week
dietary lifestyle2 yearsvariations in intake of simple sugars, animal protein rich foods, saturated fats and cholesterol, UDM: grams/die. All the informations will be collected using 5days food diaries, completed by the patients.

Countries

Italy

Contacts

Primary ContactEmanuela Orsi, MD
emanuela_orsi@yahoo.it0255034590
Backup Contactvaleria grancini, MD
valeria_grancini@hotmail.it0039 3926233299

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026